semaglutide submagna | NextGenRx Compound Pharmacy SUBMAGNA® SL HMW - PCCA

31:36 Leadership, Growth & Managing Success 37:28 Social Media, Misinformation & Peptides 41:05 Why China Dominates the Peptide Industry 46:22 The Reality of Starting a Peptide Company Today 50:52 Educating Doctors & Growing the Industry 53:08 The Future of Peptides & Telehealth 57:20 Final Thoughts & Closing Advice We cover: How it all started Started synthesizing peptides from scratch 12 years ago with $30,000 and a small lab Spent 7 years building with almost no market nobody knew what peptides were Built a 20,000 doctor network and scaled to $170180M in under 2 years Now operates 44+ companies including telehealth, pharmacies, drug manufacturing, research, cosmetics, hair restoration, and more 500800 employees across multiple sites What he's built Three telehealth companies and three 503A pharmacies 50-state hormone license supplies Walgreens, CVS, and rare disease medications to every major university in the US Two 503B sterile injectable facilities (two more being built) Research manufacturing sites running 1214 IRBs and INDs per year AlphaSync described as Amazon for doctors, full platform for ordering peptides and hormones at a fraction of market cost New brick-and-mortar wellness center opening: IV, hyperbaric, red light, full gym, laser treatments all under a membership model What's coming peptides to watch FLGR-242 (Follistatin 242): modified follistatin that actually adds muscle one of the most exciting muscle builders emerging Lepto: GLP + GIP + Glucagon + IGF-1 once every two weeks injection, helps with weight loss while protecting muscle from wasting Albumin-bound semaglutide: 1/10th the normal dose with the same result no receptor burnout Oral peptide delivery system: coats peptide to survive digestion, bypasses liver, enters lymphatic system 24x more bioavailable in models

The Maintenance Trap: Why Most People Regain Post-GLP-1 Weight regain is generally expected when people discontinue taking GLP-1s

Diabetes Care 1992;15:270276.ArticlePubMed 85

GLP-1s (glucagon-like peptide-1 receptor agonists) are great to lose 30 to 50 pounds, he shares

& Bluck, L

Supporting Evidence: Studies have shown fasting insulin is a more sensitive early marker of metabolic dysfunction compared to glucose alone (Reaven, 1988)